Drug major Pfizer announced completion of the merger with pharmaceutical company, Wyeth. The merger places Pfizer among the top ten drug companies in India by market share. As a result of the merger with Wyeth, Pfizer now has a significantly stronger portfolio of offerings across a wider therapeutic universe.
Pfizer Inc, USA, through its subsidiaries holds the majority stake in both companies and will continue to remain the majority shareholder with around 63.9 per cent holding in Pfizer post-merger.
The company has debuted offering in vaccines segment and has planned to build a robust presence in areas of women's health with best known brands in Oral contraception and folic acid supplements. Pfizer reported a standalone loss of Rs 11.83 crore for the second quarter of current fiscal as compared to net profit of Rs 69.45 crore for same quarter of previous fiscal.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1659.80 |
| Dr. Reddys Lab | 1234.50 |
| Cipla | 1214.25 |
| Zydus Lifesciences | 923.60 |
| Lupin | 2323.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: